COSM Market Analysis

Overview

Fundamentals

P/E ratioForward 25.00
EPS (TTM)$-0.660.0% YoY
Profit margin-30.4%HEALTHCARE
Market cap$15.0MMicro cap

Valuation

Forward P/E
25.00
PEG ratio
0.00
P/B
0.78
P/S (TTM)
0.22
EV/EBITDA
-1.60

Profitability & growth

ROE (TTM)
-92.3%
Operating margin
-12.2%
Revenue growth YoY
30.7%
Dividend yield
Beta
4.12
Last earnings
May 20, 2026 · Estimate $-0.01 · Reported $-0.03
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Cosmos Health Inc.

Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
5 AGIOU GEORGIOU STR, PILEA, THESSALONIKI
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$15.0M
Shares outstanding$62.1M
52W high$1.32
52W low$0.18

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer